View text source at Wikipedia

Pidotimod

Pidotimod
Clinical data
Other names(4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • (4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H12N2O4S
Molar mass244.27 g·mol−1
3D model (JSmol)
  • O=C(O)[C@H]2N(C(=O)[C@H]1NC(=O)CC1)CSC2
  • InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1 checkY
  • Key:UUTKICFRNVKFRG-WDSKDSINSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pidotimod is an immunostimulant.[1]

References

[edit]
  1. ^ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of Pharmacal Research. 31 (9): 1153–9. doi:10.1007/s12272-001-1282-6. PMID 18806958. S2CID 207408882.


Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.